Search - tctmd.com

Displaying 1 - 20 of 49

Sort: Relevancy | Date

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

News Daily News

Moderate-Intensity Exercise Possible For Patients With Statin Side Effects

Michael O'Riordan

April 03, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Conference News EAS 2019

FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis

Michael O'Riordan

June 03, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

L.A. McKeown

January 11, 2018

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

News Conference News ESC 2017

Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets

Michael O'Riordan

August 30, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

Statins Seem to Reduce Alzheimer’s Disease Risk, But Race/Ethnicity and Statin Type Matter

Todd Neale

December 14, 2016

News Daily News

Al parecer las estatinas reducen el riesgo de la Enfermedad de Alzheimer, pero se deben tener en cuenta el tipo de estatina y la raza/etnicidad.

Todd Neale

December 14, 2016

News Daily News

High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients

Michael O'Riordan

November 10, 2016

News Daily News

El Tratamiento con Estatinas de Alta Intensidad Ofrece una Mayor Supervivencia sobre las Estatinas de Intensidad Moderada en Pacientes con Enfermedad Cardiovascular

Michael O'Riordan

November 10, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Michael O'Riordan

October 18, 2016

Advertisement

Need a Statin for Primary Prevention? There’s an App for That

Moderate-Intensity Exercise Possible For Patients With Statin Side Effects

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Diabetes Progression in Statin-Treated Patients: VA Data

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis

TCTMD’s Top 10 Most Popular Stories for January 2018

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

Statins and Diabetes: Causal Link Reinforced in New Analysis

Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Statins Seem to Reduce Alzheimer’s Disease Risk, But Race/Ethnicity and Statin Type Matter

Al parecer las estatinas reducen el riesgo de la Enfermedad de Alzheimer, pero se deben tener en cuenta el tipo de estatina y la raza/etnicidad.

High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients

El Tratamiento con Estatinas de Alta Intensidad Ofrece una Mayor Supervivencia sobre las Estatinas de Intensidad Moderada en Pacientes con Enfermedad Cardiovascular

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content